Advertisement

Topics

Procognia Inc. Company Profile

18:21 EDT 17th June 2018 | BioPortfolio

Procognia is helping to develop a fuller understanding of proteins as targets and as therapeutics. Utilising technologies based around proteins arrays, we provide both the means for unraveling disease mechanisms and the discovery and development of drugs to treat those diseases. Procognia uses protein arrays to understand the function of proteins and their post-translational modifications, particularly glycosylation. Using our products, we can mine the human proteome for knowledge and therapies.As a company, we partner in applications where our customers need a range of readily available products to further their research. We commercialise our products directly where our customers need a close relationship with their technology supplier to tailor our products to their needs. We seek to develop future partnerships that maximise the utility of our platforms to increase applications for our customers.Founded in April 2002, Procognia is headquartered in the UK. The Company’s discovery and research are carried out in the UK and Israel. Development, sales and support are based in the UK, the US and Japan.

Location

The Arboretum, Suite 14760 Constitution Drive
Exton
Pennsylvania
19341
United States of America

Contact

Phone: 1 610 321-2520
Fax: 1 610 321-2521
Email: info@procognia.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Procognia Ltd.

Procognia is helping to develop a fuller understanding of proteins as targets and as therapeutics. Utilising technologies based around proteins arrays, we provide both the means for unraveling disease...

Procognia Inc.

Procognia is helping to develop a fuller understanding of proteins as targets and as therapeutics. Utilising technologies based around proteins arrays, we provide both the means for unraveling disease...

Procognia Group

Nil

Sense Proteomic Limited

Sense Proteomic Limited is a biomarker discovery company utilising its proprietary protein array technology to discover and commercialise autoantibody biomarkers for cancer and autoimmune diseases. We...

More Information about "Procognia Inc." on BioPortfolio

We have published hundreds of Procognia Inc. news stories on BioPortfolio along with dozens of Procognia Inc. Clinical Trials and PubMed Articles about Procognia Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Procognia Inc. Companies in our database. You can also find out about relevant Procognia Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record